Skip to main content

Vertex Pharmaceuticals net income

  • VRTX · Nasdaq
  • Pharmaceuticals
  • Biotechnology
  • S&P 500
$538.60−0.74%Close 13 Nov 2026

Vertex Pharmaceuticals's net income was $3.95 billion for fiscal year 2025 (the twelve months to 31 Dec 2025).

In the third quarter of fiscal 2026 (the three months to 30 Sep 2026) it was $654 million, down 39.6% from a year earlier.

Over the four quarters to 30 Sep 2026, net income was $3.98 billion.

From Vertex Pharmaceuticals's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 3 Nov 2026.

Fiscal 2025
$3.95B
Q3 FY2026
$654M
−39.6% on a year

Net income by fiscal year

−$112MFY 2016$263MFY 2017$2.10BFY 2018+696%$1.18BFY 2019−43.9%$2.71BFY 2020+130%$2.34BFY 2021−13.6%$3.32BFY 2022+41.8%$3.62BFY 2023+9.0%−$536MFY 2024$3.95BFY 2025

Change on the year before, under each year. From FY 2016 to FY 2025, Vertex Pharmaceuticals's net income went from −$112 million to $3.95 billion; FY 2025 is the highest of the period.

Vertex Pharmaceuticals net income, fiscal years
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Net income−$112M$263M$2.10B$1.18B$2.71B$2.34B$3.32B$3.62B−$536M$3.95B
Period end31 Dec 201631 Dec 201731 Dec 201831 Dec 201931 Dec 202031 Dec 202131 Dec 202231 Dec 202331 Dec 202431 Dec 2025

Net income by quarter

The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.

Vertex Pharmaceuticals net income, fiscal quarters
PeriodQ4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Net income$913M$646M$1.03B$1.08B$1.19B$1.03B$1.10B$654M
Period end31 Dec 202431 Mar 202530 Jun 202530 Sep 202531 Dec 202531 Mar 202630 Jun 202630 Sep 2026

How net income is measured

Net income is the profit left after every expense, interest and income tax, attributable to the company's shareholders. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.

Vertex Pharmaceuticals's other figures

Net income of comparable companies

Everything on VRTX, in the terminal.

Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.